Open Journal of Obstetrics and Gynecology

Vol.3 No.3(2013), Paper ID 30981, 5 pages

DOI:10.4236/ojog.2013.33064

 

Short-term Femara (letrozole) treatment and suppression of Ki67 expression in postmenopausal endometrial carcinoma

 

Lloyd H. Smith, Gary Leiserowitz, Guibo Xing, John Bishop

 

Department of Obstetrics, Gynecology and Pathology, UC Davis School of Medicine Sacramento, Sacramento, USA
Department of Obstetrics, Gynecology and Pathology, UC Davis School of Medicine Sacramento, Sacramento, USA
Department of Obstetrics, Gynecology and Pathology, UC Davis School of Medicine Sacramento, Sacramento, USA
Department of Obstetrics, Gynecology and Pathology, UC Davis School of Medicine Sacramento, Sacramento, USA

 

Copyright © 2013 Lloyd H. Smith, Gary Leiserowitz, Guibo Xing, John Bishop et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Smith, L. , Leiserowitz, G. , Xing, G. and Bishop, J. (2013) Short-term Femara (letrozole) treatment and suppression of Ki67 expression in postmenopausal endometrial carcinoma. Open Journal of Obstetrics and Gynecology, 3, 347-351. doi: 10.4236/ojog.2013.33064.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.